Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial
- Citation:
- J Clin Oncol vol 32 (15) 1563-1570
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 3
- Parents:
- 447
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, P30 CA016672, R21 CA150381, CA076001, CA106588, U10 CA031946, U10 CA033601, CA102613, R01 CA102613, P30 CA008748, P30 CA046934, R01 CA106588, CA150381, U10 CA180882, P30 CA014236, U10 CA076001, CA94503, CA033601, U10 CA180888, P50 CA127003
- Corr. Author:
- Authors:
- Christopher L. Corless Karla V. Ballman Cristina R. Antonescu Violetta Kolesnikova Robert G. Maki Peter W.T. Pisters Martin E. Blackstein Charles D. Blanke George D. Demetri Michael C. Heinrich Margaret von Mehren Shreyaskumar Patel Martin D. McCarter Kouros Owzar Ronald P. DeMatteo
- Networks:
- Study
- ACOSOG-Z9001
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Gic3, Gic6, Gic7, ORIGINAL REPORTS, Gastrointestinal Cancer